OrbiMed Capital GP III LLC, Director at GLAUKOS Corp (GKOS), sold 422,154 shares at $38.29 ($16.0M) on 2017-08-15, disclosed to the SEC on 2017-08-17.
Open-market sale of $16.0M GKOS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.29 | 307 | $12K | 0.1% |
| 2 | $38.29 | 32,193 | $1.2M | 7.7% |
| 3 | $38.29 | 32,193 | $1.2M | 7.7% |
| 4 | $38.01 | 619 | $24K | 0.1% |
| 5 | $38.01 | 64,961 | $2.5M | 15.4% |
| 6 | $38.01 | 64,961 |
| $2.5M |
| 15.4% |
| 7 | $37.85 | 2,140 | $81K | 0.5% |
| 8 | $37.85 | 224,780 | $8.5M | 53.1% |
| Total | $37.97 avg | 422,154 | $16.0M | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |